Topical pH Buffer Composition for Long-Lasting Skin Barrier Support

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing skin care products fail to maintain optimal skin surface pH over an extended period, leading to disrupted skin barrier function and increased susceptibility to conditions like eczema, acne, psoriasis, and rosacea.

Innovation Solution

Topical formulations comprising specific pH-adjusting agents and buffers, such as citric acid, sodium citrate, gluconic acid, and shea butter, are applied to maintain skin pH between 4.5 and 5.5 for an extended period, supporting ceramide production and skin microbiome health.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If existing skin care products are used, then skin surface pH control is provided, but the pH control duration is short and cannot be maintained over extended periods

Engineering Contradiction:
ImprovepH control durationVSAvoidskin barrier function maintenance
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The patent employs a combination of pH-adjusting agents (citric acid, gluconic acid, lactic acid) and buffering agents (sodium citrate, disodium EDTA, phytosphingosine) that work continuously to maintain skin surface pH within the optimal range of 4.5-5.5 for extended periods. This continuous action ensures sustained skin barrier function support without requiring frequent reapplication, directly resolving the contradiction between duration and reliability.

Inventive Principle:
Principle #20Continuity of useful action

2Reliability

If pH-adjusting agents are applied frequently to maintain pH, then pH control is improved, but application complexity and user burden increase

Engineering Contradiction:
Improveskin barrier function maintenanceVSAvoidapplication frequency requirement
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The formulation is designed to be self-regulating through its buffer system. Once applied, the combination of weak acids (citric acid pKa 3.13, gluconic acid pKa 3.7, lactic acid pKa 3.86) and their conjugate bases creates a buffer capacity that automatically maintains pH within the target range of 4.5-5.5 without requiring frequent monitoring or reapplication. This self-service mechanism reduces user burden while maintaining reliable skin barrier support.

Inventive Principle:
Principle #25Self-service

3Duration of action of moving object

If strong buffering agents are used to extend pH control duration, then duration is improved, but skin irritation risk increases

Engineering Contradiction:
ImprovepH control durationVSAvoidskin irritation
Core Design Contradiction:
Duration of action of moving objectVSObject-affected harmful factors

Solution Approach 1:

The patent carefully selects pH-adjusting agents with specific pKa values (citric acid pKa 3.13, gluconic acid pKa 3.7, lactic acid pKa 3.86) that are optimized to maintain skin surface pH within the physiological range of 4.5-5.5. These parameters are chosen to provide effective buffering without causing irritation, extending pH control duration while maintaining skin compatibility. The gradual release profile of these agents ensures prolonged effect without harshness.

Inventive Principle:
Principle #35Parameter changes

4Manufacturing precision

If multiple pH-adjusting agents are combined to enhance effectiveness, then pH control precision is improved, but formulation complexity increases

Engineering Contradiction:
ImprovepH control precisionVSAvoidformulation complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple pH-adjusting agents (citric acid, gluconic acid, lactic acid) with complementary pKa values in a single formulation, along with buffering agents (sodium citrate, disodium EDTA, phytosphingosine). This merging creates a synergistic buffer system that maintains pH precision across varying skin conditions and environmental factors. The combined approach provides robust pH control without requiring multiple separate products or complex application routines.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulations stabilize skin pH for up to 12 hours, reducing eczema symptoms and enhancing skin barrier function without irritation, thereby improving skin health and preventing conditions like eczema, acne, and psoriasis.

Implementation Method 1

maintaining a first pH buffer at a target skin area between 4.5 and 5.5 for a first period of time by applying a first composition to the target skin area, the first composition with a first buffer capacity concentration of acids and conjugate bases

Methodology Applied
Scientific EffectpH buffering:

Data Source

PatentUS12616669B2Methods and chemical compositions for treating skin conditions by providing long lasting skin pH control for improving skin barrier function
Publication Date: 2026.05.05 SOTERI SKIN INC
  • US12616669B2 patent drawing
  • US12616669B2 patent drawing
  • US12616669B2 patent drawing

AI summary

Provided are methods and composition for treating skin barrier functions and associated disorders. Formulated compositions may be applied on human skin to maintain a desired skin surface pH over an extended period of time without irritating the skin. Maintaining the desired surface pH aids in treatment of eczema, in addition to other skin conditions.